Live Case Broadcasting from Georgia Heart Institute | Gainesville, GA

Sunday, March 9, 2025

8:00 AM – 8:45 AM ET

Live Case Operator(s)

Stephane Rinfret, MD, SM

Director of Complex Coronary Interventions
Georgia Heart Institute
Gainesville, Georgia, United States

Disclosure(s): Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)

Panel Moderator(s)

Lorenzo Azzalini, MD, PhD, MSc

Interventional Cardiologist
University of Washington
Seattle, Washington, United States

Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)
Kevin Croce, MD, PhD

Director of CTO and Complex PCI Programs
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts, United States

Disclosure information not submitted.

Panel Discussant(s)

Emmanouil S. Brilakis, MD, PhD

Director, Center for Advanced Coronary Interventions
Minneapolis Heart Institute
Minneapolis, Minnesota, United States

Disclosure(s): Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); boston scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Elsevier Publishing: royalties (Ongoing); GE Healthcare: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing); Hippocrates LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); IMDS: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Stallion Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TrueVue Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Darshan Doshi, MD, MS

Interventional Cardiologist
Massachusetts General Hospital / Harvard Medical School, Massachusetts, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing); Acist Medical: Consultant (Ongoing); Cordis Inc.: Consultant (Ongoing); Philips: Employee (Ongoing); Shockwave Medical: Consultant (Ongoing)
Allison B. Hall, MD, FRCPC

Interventional Cardiologist, Clinical Assistant Professor of Medicine
NL Health Services/Memorial University of Newfoundland
St. John's, Newfoundland and Labrador, Canada

Disclosure(s): No financial relationships to disclose
Tarek Helmy, MD, FACC, MSCAI

Chief of Cardiology and Director of Cardiac Cath Lab
Ochsner LSU
Shreveport, Louisiana, United States

Disclosure(s): medtronic.: proctor for TAVR (Ongoing)
Gautam Kumar, MD, FSCAI

Professor
Emory University / Atlanta VA Medical Center
Atlanta, Georgia, United States

Disclosure(s): Merit Medical Systems Inc: Consulting Fees (e.g., advisory boards) (Ongoing)
Shigeru Saito, MD, FACC, FSCAI

Director, Heart Center
Shonan Kamakura General Hospital
Kamakura, Kanagawa, Japan

Disclosure(s): Elixir: Consulting Fees (e.g., advisory boards) (Ongoing)
Alpesh Shah, MD

Director of Coronary Interventions, Associate Professor
Houston Methodist Hospital
Houston, Texas, United States

Disclosure(s): Abbott Labs: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed Inc: Grant/Research Support (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Gerald S. Werner, MD, PhD, FSCAI

Director
Klinikum Darmstadt GmbH
Darmstadt, Hessen, Germany

Disclosure(s): Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)
Masahisa Yamane, MD

Senior Advisor
Saitama Sekishinkai Hospital
Tokyo, Tokyo, Japan

Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Stephane Rinfret, MD, SM: Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)

Lorenzo Azzalini, MD, PhD, MSc: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)

Emmanouil S. Brilakis, MD, PhD: Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); boston scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Elsevier Publishing: royalties (Ongoing); GE Healthcare: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing); Hippocrates LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); IMDS: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Stallion Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TrueVue Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Darshan Doshi, MD, MS: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing); Acist Medical: Consultant (Ongoing); Cordis Inc.: Consultant (Ongoing); Philips: Employee (Ongoing); Shockwave Medical: Consultant (Ongoing)

Allison B. Hall, MD, FRCPC: No financial relationships to disclose

Tarek Helmy, MD, FACC, MSCAI: medtronic.: proctor for TAVR (Ongoing)

Gautam Kumar, MD, FSCAI: Merit Medical Systems Inc: Consulting Fees (e.g., advisory boards) (Ongoing)

Shigeru Saito, MD, FACC, FSCAI: Elixir: Consulting Fees (e.g., advisory boards) (Ongoing)

Alpesh Shah, MD: Abbott Labs: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed Inc: Grant/Research Support (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Gerald S. Werner, MD, PhD, FSCAI: Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

Masahisa Yamane, MD: Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing)